Increased endogenous endothelin-1 in coronary circulation is associated with restenosis after coronary angioplasty

Canadian Journal of Cardiology

Volumn 19, Issue 8, 2003, Pages 902-906

  Takase, Hiroyuki ^a   Sugiyama, Masaya ^b   Nakazawa, Ai ^c   Toriyama, Takayuki ^a   Hayashi, Kunihiko ^b   Goto, Takatoshi ^a   Sato, Koichi ^b   Ikeda, Koshiro ^c   Ueda, Ryuzo ^b   Dohi, Yasuaki ^b  

^a Enshu General Hospital   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c Toyokawa City Hospital   (Japan)

Author keywords

Angina; Angioplasty; Coronary disease; Endothelin; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN; ANTITHROMBOCYTIC AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; HEPARIN; ISOSORBIDE DINITRATE; NITRATE; NITRIC OXIDE; NITRITE; NORADRENALIN; SEROTONIN; VASOACTIVE AGENT; ANGIOTENSIN II; BIOLOGICAL MARKER;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY RISK; CORONARY SINUS; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RESTENOSIS; RISK ASSESSMENT; SEROTONIN BLOOD LEVEL; STENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR PATENCY; BLOOD; COMPARATIVE STUDY; HEMODYNAMICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; STATISTICS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN II; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY RESTENOSIS; ENDOTHELIN-1; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NOREPINEPHRINE; RISK FACTORS; SEROTONIN; STATISTICS; VASCULAR PATENCY;

EID: 0041913987     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991;84:1426-36.
2. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton: CRC Press, 1990.
3. Borries M, Heins M, Fischer Y, et al. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina. J Am Coll Cardiol 1999;34:486-93.
4. Kirchengast M, Munter K. Endothelin and restenosis. Cardiovasc Res 1998;39:550-5.
5. George SE. Nitric oxide and restenosis: Opportunities for therapeutic intervention. Coron Artery Dis 1999;10:295-300.
6. Kastrati A, Dirschinger J, Schomig A. Genetic risk factors and restenosis after percutaneous coronary interventions. Herz 2000;25:34-46.
7. Watanabe T, Pakala R, Katagiri T, Benedict CR. Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation. J Hypertens 2001;19:731-9.
8. Lüscher TF, Barton M. Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000;102:2434-40.
9. Myers PR, Webel R, Thondapu V, et al. Restenosis is associated with decreased coronary artery nitric oxide synthase. Int J Cardiol 1996;55:183-91.
10. Ryan TJJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committe on Percutaneous Transluminal Coronary Angioplasty). Circulation 1993;88:2987-3007.
11. Anderson GM, Feibel FC, Wetlaufer LA, Schlicht KR, Ort SM, Cohen DJ. Effect of a meal on human whole blood serotonin. Gastroenterology 1985;88:86-9.
12. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
13. Douglas SA, Louden C, Vickery Clark LM, et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 1994;75:190-7.
14. Dashwood MR, Noertersheuser P, Kirchengast M, Munter K. Altered endothelin-1 binding following balloon angioplasty of pig coronary arteries: Effect of the ETA receptor antagonist, LU 135252. Cardiovasc Res 1999;43:445-56.
15. Minamino T, Kurihara H, Takahashi M, et al. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 1997;95:221-30.
16. Wang X, Douglas SA, Feuerstein GZ, Ohlstein EH. Temporal expression of ECE-1, ET-1, ET-3, ETA, and ETB receptor mRNAs after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1995;26:S22-5.
17. Ferrer P, Valentine M, Jenkins West T, et al. Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries. J Cardiovasc Pharmacol 1995;26:908-15.
18. Krüger D, Giannitsis E, Sheikhzadeh A, Stierle U. Cardiac release and kinetics of endothelin after uncomplicated percutaneous transluminal coronary angioplasty. Am J Cardiol 1998;81:1421-6.
19. Petronio AS, Amoroso G, Limbruno U, et al. Endothelin-1 release from atherosclerotic plaque after percutaneous transluminal coronary angioplasty in stable angina pectoris and single-vessel coronary artery disease. Am J Cardiol 1999;84:1085-8,A9.
20. Hasdai D, Holmes DR Jr, Garratt KN, Edwards WD, Lerman A. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation 1997;95:357-62.
21. Lablanche JM, Grollier G, Lusson JR, et al. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem. Circulation 1997;95:83-9.
22. Golino P, Piscione F, Benedict CR, et al. Local effect of serotonin released during coronary angioplasty. N Engl J Med 1994;330:523-8.
23. Brum JM, Sufan Q, Lane G, Bove AA. Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs. Circulation 1984;70:1066-73.
24. Leosco D, Fineschi M, Pierli C, et al. Intracoronary serotonin release after high-pressure coronary stenting. Am J Cardiol 1999;84:1317-22.
25. Ohishi M, Ueda M, Rakugi H, et al. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. Circulation 1997;96:3328-37.
26. Wilson DP, Saward L, Zahradka P, Cheung PK. Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model. Cardiovasc Res 1999;42:761-72.
27. Franco-Cereceda A, Grip LG, Moor E, Velander M, Liska J, Lundberg JM. Influence of percutaneous transluminal coronary angioplasty on cardiac release of endothelin, neuropeptide Y and noradrenaline. Int J Cardiol 1995;48:231-3.